Table 2 Mean annual patient cost of haemodialysis (HD) and ESRD management (USD)
From: Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria
Cost item | Mean | Std. Deviation | Proportion of Annual HD cost (%) | Proportion of Annual ESRD cost (%) |
|---|---|---|---|---|
Drugs | 2,037.44 | 2,523.71 | 45.8 | 27.5 |
Laboratory | 1,356.50 | 1,714.54 | 30.5 | 18.3 |
Transport | 589.63 | 756.29 | 13.3 | 8.0 |
Feeding | 463.74 | 487.16 | 10.4 | 6.3 |
Diabetes | 152.08 | 792.33 | 2.1 | |
Hypertension | 654.94 | 2,925.39 | 8.8 | |
Cardiovascular disease | 43.79 | 345.25 | 0.6 | |
Anaemia | 709.52 | 8,411.54 | 9.6 | |
Osteoporosis | 1.63 | 19.08 | 0.0 | |
Sexual dysfunction | 2.77 | 42.05 | 0.0 | |
Depression | 25.41 | 287.51 | 0.3 | |
Other comorbidities | 1,378.08 | 3,056.45 | 18.6 | |
Annual patient HD cost ($) | 4,447.32 | 4,193.88 | 60.0 | |
Annual patient ESRD cost ($) | 7,415.55 | 12,063.37 | ||
Unit cost HD session | 28.51 | 26.88 |